Диссертация (1140838), страница 18
Текст из файла (страница 18)
31(19). — P. 2369–2429.40. Carubelli, V. Prognostic value of the absolute lymphocyte count in patientsadmitted for acute heart failure / V. Carubelli, I. Bonadei, A. I. Castrini [et al.]// J Cardiovasc Med (Hagerstown). — 2017. — Vol. 18(11). — P. 859–865.41. Chaitman, M.Potassium-binding agents for the clinical management ofhyperkalemia / M. Chaitman, D.
Dixit, M. B. Bridgeman // P T. — 2016.— Vol. 41(1). — P. 43–50.42. Collier, T. J. The impact of eplerenone at different levels of risk in patients withsystolic heart failure and mild symptoms: insight from a novel risk score forprognosis derived from the EMPHASIS-HF trial / T. J. Collier, S. J.
Pocock,J. J. McMurray [et al.] // Eur Heart J. — 2013. — Vol. 34(36). — P. 2823–2829.11543. Collins, A. J. Association of serum potassium with all-cause mortality in patientswith and without heart failure, chronic kidney disease, and/or diabetes/ A. J. Collins, B. Pitt, N. Reaven [et al.] // Am J Nephrol. — 2017.
— Vol. 46(3).— P. 213–221.44. Daniels, L. B.Cardiovascular biomarkers and sex: the case for women/ L. B. Daniels, A. S. Maisel // Nat Rev Cardiol. — 2015. — Vol. 12(10).— P. 588–596.45. Davis, J. D. All-payer analysis of heart failure hospitalization 30-day readmission:comorbidities matter / J. D. Davis, M. A. Olsen, K. Bommarito [et al.] // Am JMed. — 2017. — Vol. 130(1). — P. 93.e9–93.e28.46. Deubner, N. Dysnatraemia in heart failure / N. Deubner, D. Berliner, A.
Frey [et al.]// Eur J Heart Fail. — 2012. — Vol. 14(10). — P. 1147–1154.47. DeVore, A. D. Development and validation of a risk model for in-hospitalworsening heart failure from the Acute Decompensated Heart Failure NationalRegistry (ADHERE) / A. D. DeVore, M. A. Greiner, P.
P. Sharma [et al.] // AmHeart J. — 2016. — Vol. 178. — P. 198–205.48. DeWolfe, A. Low serum sodium as a poor prognostic indicator for mortality incongestive heart failure patients / A. DeWolfe, B. Lopez, L. M. Arcement,K. Hebert // Clin Cardiol. — 2010. — Vol. 33(12). — P. E13–E17.49. Doehner, W. Metabolic impairment in heart failure: the myocardial and systemicperspective / W. Doehner, M.
Frenneaux, S. D. Anker // J Am Coll Cardiol.— 2014. — Vol. 64(13). — P. 1388–1400.50. Dursun, J. Difficulties in maintaining potassium homeostasis in patients with heartfailure / J. Dursun, M. Sahin // Clin Cardiol. — 2006. — Vol. 29(9). — P. 388–392.51. Dworzynski, K. Diagnosing and managing acute heart failure in adults: summaryof NICE guidance [Electronic resource] / K. Dworzynski, E. Roberts, A. Ludman,J Mant // BMJ. — Vol. 349. — P. g5695. — doi:10.1136/bmj.g569511652.
Emdin, C. A. Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the NationalHeart Failure Audit for England and Wales) / C. A. Emdin, A. J. Hsiao, A. Kiran[et al.] // Am J Cardiol. — 2017. — Vol. 119(3). — P. 440–444.53. Felker, G. M. Diuretic Strategies in Patients with Acute Decompensated HeartFailure / G. M. Felker, K. L. Lee, D. A. Bull [et al.] // N Engl J Med. — 2011.— Vol. 364(9). — P.
797–805.54. Filippatos, T. D. Hyponatremia in patients with heart failure / T. D. Filippatos,M. S. Elisaf // World J Cardiol. — 2013. — Vol. 5(9). — P. 317–328.55. Freda, B. J. Effect of transient and sustained acute kidney injury on readmissions inacute decompensated heart failure / B. J. Freda, A. B. Knee, G. L. Braden[et al.] // Am J Cardiol. — 2017. — Vol.
119(11). — P. 1809–1814.56. Gaggin, H. K. Heart failure outcomes and benefits of NT-proBNP-Guidedmanagement in the elderly: results from the Prospective, Randomized ProBNPOutpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study /H. K. Gaggin, A.
A. Mohammed, A. Bhardwaj [et al.] // J Card Fail. — 2012.— Vol. 18(8). — P. 626–634.57. Ganiger, H. Dysnatraemia in heart failure: a descriptive study / H. Ganiger,A. G. Ravishankar // Int J Sci Study. — 2015. — Vol. 3(6). — P. 81–85.58. Gheorghiade, M. Characterization and prognostic value of persistent hyponatremiain patients with severe heart failure in the ESCAPE Trial / M. Gheorghiade,J.
S. Rossi, W. Cotts [et al.] // Arch Intern Med. — 2007. — Vol. 167(18).— P. 1998–2005.59. Gheorghiade, M. Rehospitalization for heart failure: problems and perspectives /M. Gheorghiade, M. Vaduganathan, G. C. Fonarow, R. O. Bonow // J Am CollCardiol. — 2013. — Vol. 61(4). — P.
391–403.11760. Gheorghiade, M. Relationship between admission serum sodium concentration andclinical outcomes in patients hospitalized for heart failure: an analysis from theOPTIMIZE-HF registry / M. Gheorghiade, W. T. Abraham, N. M. Albert [et al.]// Eur Heart J. — 2007. — Vol. 28(8). — P.
980–988.61. Girerd, N. Serum aldosterone is associated with mortality and re-hospitalization inpatients with reduced ejection fraction hospitalized for acute heart failure: analysisfrom the EVEREST trial / N. Girerd, P. S. Pang, K. Swedberg [et al.] // Eur J HeartFail. — 2013. — Vol. 15(11). — P. 1228–1235.62. Greene, S. J. Thevulnerable phase after hospitalization for heart failure/ S.
J. Greene, G. C. Fonarow, M. Vaduganathan [et al.] // Nat Rev Cardiol.— 2015. — Vol. 12(4). — P. 220–229.63. Grodin, J. L. Implications of serum chloride homeostasis in acute heart failure(from ROSE-AHF) / J. L. Grodin, J. L. Sun, K. J. Anstrom [et al.] // Am J Cardiol.— 2017. — Vol. 119(1). — P. 78–83.64. Grodin, J. L. Importance of Abnormal Chloride Homeostasis in Stable ChronicHeart Failure / J. L. Grodin, F. H. Verbrugge, S. G. Ellis [et al.] // Circ Heart Fail.— 2016.
— Vol. 9(1). — P. e002453.65. Grodin, J. L. Prognostic role of serum chloride levels in acute decompensated heartfailure / J. L. Grodin, J. Simon, R. Hachamovitch [et al.] // J Am Coll Cardiol.— 2015. — Vol. 66(6). — P. 659–666.66. Gronda, E. Baroreflex activation therapy: a new approach to the management ofadvanced heart failure with reduced ejection fraction / E. Gronda, D. Francis, F.Zannad [et al.] // J Cardiovasc Med (Hagerstown). — 2017 — Vol. 18(9).— P. 641–649.67.
Ho, K. K. The epidemiology of heart failure: the Framingham Study / K. K. Ho,J. L. Pinsky,W. B. Kannel,D. Levy— Vol. 22 (4 Suppl A). — P. 6A–13A.//JAmCollCardiol.— 1993.11868. Hoss, S. Serum potassium levels and outcome in patients with chronic heartfailure / S. Hoss, Y. Elizur, D.
Luria [et al.] // Am J Cardiol. — 2016.— Vol. 118(12). — P. 1868–1874.69. Iqbal, J. Displacement of cortisol from human heart by acute administration of amineralocorticoid receptor antagonist / J. Iqbal, R. Andrew, N. L. Cruden [et al.]// J Clin Endocrinol Metab. — 2014. — Vol.
99(3). — P. 915–922.70. Kajimoto, K. Association of admission and discharge anemia status with outcomesin patients hospitalized for acute decompensated heart failure: differences betweenpatients with preserved and reduced ejection fraction [Electronic resource]/ K. Kajimoto, Y. Minami, S. Otsubo, N.
Sato // Eur Heart J Acute Cardiovasc Care.— 2017. — doi:10.1177/204887261773003971. Kajimoto, K. Gender differences in anemia and survival in patients hospitalized foracute decompensated heart failure with preserved or reduced ejection fraction /K. Kajimoto, Y. Minami, N. Sato [et al.] // Am J Cardiol. — 2017. — Vol.
120(3).— P. 435–442.72. Kemp, W. L. Cardiac pathology / W. L. Kemp // Pathology. The big picture/W. L. Kemp,D. K. Burns,T. G. Brown.— USA : McGraw-Hill, 2008.— Chapter 10. — P. 109–132.73. Khan, S. S. Changes in serum potassium levels during hospitalization in patientswith worsening heart failure and reduced ejection fraction (from the EVERESTtrial) / S. S. Khan, U.
Campia, O. Chioncel [et al.] // Am J Cardiol. — 2015.— Vol. 115(6). — P. 790–796.74. Khera, A. V. Genetic risk, adherence to a healthy lifestyle, and coronary disease/ A. V. Khera, C. A. Emdin, I. Drake [et al.] // N Engl J Med. — 2016.— Vol. 375(24). — P. 2349–2358.75. Kjeldsen, K. Hypokalemia and sudden cardiac death / K.
Kjeldsen // Exp ClinCardiol. — 2010. — Vol. 15(4). — P. e96–e99.11976. Klein, L. Lower serum sodium is associated with increased short-term mortality inhospitalized patients with worsening heart failure. Results from the Outcomes of aProspective Trial of Intravenous Milrinone for Exacerbations of Chronic HeartFailure (OPTIME-CHF) study / L.
Klein, C. M. O'Connor, J. D. Leimberger[et al.] // Circulation. — 2005. — Vol. 111(19). — P. 2454–2460.77. Klempfner, R. The Israel Nationwide Heart Failure Survey: sex differences in earlyand late mortality for hospitalized heart failure patients / R. Klempfner,E. Koifman, I. Goldenberg [et al.] // J Card Fail. — 2014. — Vol. 20(3).— P. 193–198.78. Kovesdy, C. P.
Hyponatremia, hypernatremia, and mortality in patients withchronic kidney disease with and without congestive heart failure / C. P. Kovesdy,E. H. Lott, J. L. Lu [et al.] // Circulation. — 2012. — Vol. 125(5). — P. 677–684.79. Kusaka, H. Low-normal serum sodium and heart failure-related events in patientswith heart failure with preserved left ventricular ejection fraction / H. Kusaka,S. Sugiyama, E. Yamamoto [et al.] // Circ J. — 2016. — Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
